Innovative Solution in APEC Diagnosis: Outcomes of the Latest Research
A team of scientists from Proteon Pharmaceuticals, the Biobank Lodz, and the University of Agriculture in Cracow has developed an innovative method for identifying strains
Proteon Pharmaceuticals Obtains Polish Patent for Innovative Bacteriophage Strains in Aquaculture
We are excited to announce that our bacteriophage-based technology has been granted patent protection by the Polish Patent Office. The invention, “Bacteriophage strains and their
Phage Focus: Revisiting our BAFASAL® Research
Our research, published in 2020 in Viruses (MDPI), titled ‘Comprehensive Evaluation of the Safety and Efficacy of BAFASAL® Bacteriophage Preparation for the Reduction of Salmonella
2024: A Year of Progress and Innovation at Proteon Pharmaceuticals
We are pleased to share the significant progress Proteon Pharmaceuticals made in 2024. Our company strengthened its market position, advanced its research initiatives, and expanded
Proteon Pharmaceuticals Enhances Portfolio with BAFASAL PRO Registration in Brazil
Proteon Pharmaceuticals is delighted to announce that the Ministry of Agriculture, Livestock Farming and Supplies (MAPA) in Brazil has registered BAFASAL PRO, our latest bacteriophage-based
Breaking News: EFSA Confirms BAFASAL®’s Efficacy in Poultry Production
Proteon Pharmaceuticals is excited to announce that the European Food Safety Authority (EFSA) has published a positive scientific opinion on our innovative product BAFASAL®. The